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Abstract
Background: Recent quality control of complex mixtures, including herbal medicines, is not limited to chemical
chromatographic definition of one or two selected compounds; multivariate linear regression methods with
dimension reduction or regularisation have been used to predict the bioactivity capacity from the
chromatographic fingerprints of the herbal extracts. The challenge of this type of analysis requires a multi-
dimensional approach at two levels: firstly each herb comprises complex mixtures of active and non-active
chemical components; and secondly there are many factors relating to the growth, production, and processing of
the herbal products. All these factors result in the significantly diverse concentrations of bioactive compounds in
the herbal products. Therefore, it is imminent to have a predictive model with better generalisation that can
accurately predict the bioactivity capacity of samples when only the chemical fingerprints data are available.
Results: In this study, the algorithm of Stacking Multivariate Linear Regression (SMLR) and a few other commonly
used chemometric approaches were evaluated. They were to predict the Cluster of Differentiation 80 (CD80)
expression bioactivity of a commonly used herb, Astragali Radix (AR), from the corresponding chemical
chromatographic fingerprints. SMLR provides a superior prediction accuracy in comparison with the other
multivariate linear regression methods of PCR, PLSR, OPLS and EN in terms of MSEtest and the goodness of
prediction of test samples.
Conclusions: SMLR is a better platform than some multivariate linear regression methods. The first advantage of
SMLR is that it has better generalisation to predict the bioactivity capacity of herbal medicines from their
chromatographic fingerprints. Future studies should aim to further improve the SMLR algorithm. The second
advantage of SMLR is that single chemical compounds can be effectively identified as highly bioactive
components which demands further CD80 bioactivity confirmation..
Background
For thousands of years, herbal medicines have played a
critical role in the primary health care systems for pre-
vention and treatment of diseases, especially in Asian
countries, such as China, India, Korea and Japan [1].
However, the therapeutic efficacies of herbal medicines
are not evaluated or quantified due to the complexity of
herbal extracts [2]. Herbal medicines contain complex
compositions. A single herb may already include hun-
dreds of natural constituents. In addition, synergistic or
antagonistic interactive effects may exist among these
compounds. Furthermore, the concentrations of active
ingredients of a herb may vary substantially in different
climates, cultivation conditions, storage conditions,
extraction procedures, and other unknown factors [3].
This means that the bioactivity of herbal products for
different batches may not be consistent, and this in turn
may lead to unpredictable clinical therapeutic effects of
these herbal products.
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It is highly desirable to have a robust and efficient way
to predict the bioactivity of herbal medicines. The use of
whole chromatographic fingerprints is popular in solving
herbal medicines’ bioactivity prediction problems because
the fingerprint provides a more comprehensive picture of
herbal medicines [4]. A chromatographic fingerprint is a
two-dimensional curve with time (min) as x-axis and
intensity (mAU) as y-axis. There are two inherent charac-
teristics of chromatographic fingerprints that should be
noted. Firstly, as the intensity at every measuring time
point in a chromatographic fingerprint is treated as the
predictor variable, the number of predictor variables is
normally larger than the number of samples investigated.
This means that the intensity at every measuring time
point will be treated as the predictor variable. For
instance, a routine HPLC chromatographic fingerprint
may contain about 10,000 time points within a 70 min-
utes’ elution run constitute the high number of predictor
variables in comparison with the limited number of the
generally less than 100 grossly identified series of “peaks”
in the chromatographic fingerprints.
Secondly, a chromatographic fingerprint may contain
predictor variables that are not of high intensity due to
different UV absorption rate, and contribute significantly
to the overall bioactivity. Thirdly, various forms of mul-
ticollinearity may exist among predictor variables where
some variables can be highly complementary.
A review of the literature shows that Principal Com-
ponent Regression (PCR), Partial Least Squares Regres-
sion (PLSR), and variants of PLSR, such as Orthogonal
Projections to Latent Structures (OPLS) and Elastic Net
(EN) combined with PLSR (EN-PLSR), have been
applied in prediction of biological activity from chroma-
tographic fingerprints [2,4-12]. These approaches gener-
ate latent variables and measure the relationship
between latent representations of the chromatographic
fingerprints and bioactivities. Successful application of
these algorithms may lead to useful prediction platforms
for future bioactivity of unknown chromatographic fin-
gerprints. However, if the number of latent variables to
be used in the predictive model built by PCR, PLSR var-
iants or EN, is not properly selected, over-fitting may
occur and lead to poor generalisation performance of
these models.
Based on a set of chromatographic fingerprints of
Astragali Radix (AR) and their corresponding bioactivity
of Cluster of Differentiation 80 (CD80) expression on
the robust cell line representing human dendritic cells
(DC) measured by flow cytometry, this study aims to
propose an approach to develop predictive models with
better and accurate generalisation ability to predict the
bioactivity capacity of herbal medicines from their chro-
matographic fingerprints. Furthermore, the predictive
accuracy of the model developed by the proposed
approach will be evaluated in comparison to that of pre-
dictive models built by PCR, PLSR, OPLS and EN
respectively.
This paper is organised as follows. The Methods sec-
tion reviews the ensemble learning and describes the pro-
posed method. In the Results and Discussion section, the
performance of one real world data set is presented and
discussed. The Conclusion section summarises the
results of this study, and the Future Work section dis-
cusses potential tasks that are worthwhile for further
investigation. It is then followed by a section of abbrevia-
tions used in this paper for easy reference.
Methods
Ensemble learning
It is a critical problem to machine learning when the train-
ing set is small or extremely small. The models built with
a small training set may not be strong enough to accu-
rately predict new instances. To improve the overall pre-
diction accuracy, multiple models can be built on the
training set, and prediction is made by incorporating and
averaging over multiple models. This idea is called ensem-
ble learning [13]. Ensemble learning combines a collection
of base models (weak learners) to build a composite pre-
diction model (strong learner). There are two main tasks
of ensemble learning: constructing base models from the
training data; and combining them to form a composite
model [13]. Generally, there are three approaches to con-
struct base models, also called ensembles.
Data manipulation. The first approach is to have a
more effective use of the dataset by manipulation upon
the data. By resampling the original training set according
to a sampling distribution, such as bootstrapping, multiple
training sets will be created. Then, a model can be created
from each training-set using a learning algorithm [14].
Bagging [15] and boosting [16] are two ensemble methods
which generate base models for further processing.
Bagging is a method that repeatedly samples from a data
set according to bootstrap and train a base model on each
bootstrap sample. The base models can be combined by
simple averaging or majority voting. Bagging improves the
prediction accuracy by reducing the variance of base mod-
els. However, the performance of bagging depends on the
stability of base models [14].
Boosting is an iterative method that adaptively changes
the distribution of training samples by assigning a different
weight to each training sample. The adaptive weight
assignment to the base models aims to direct the attention
to the poorly classified or predicted training samples.
Rather than averaging the results or taking majority voting
from the ensembles, boosting combines the result from
each base model according to its weight [14].
Feature manipulation. The second approach to con-
struct base models is by to manipulate the input features,
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where each training set is formed by selecting a subset of
input features. This approach works well when the data
contain highly redundant features. The subset of features
could be selected randomly or manually according to
users’ understanding of the data and domain experience.
A typical ensemble approach in this category is Random
Forests (RF) [14]. RF [17] is a combination of decision
trees, in which each tree is generated according to the
values of a random vector that is sampled independently
and with the same distribution. It is claimed that RF is
more robust to noise and runs faster [14].
Multiple learning algorithms. The third approach to
construct base models is to use multiple learning algo-
rithms. The aim is to obtain and to make advantage of
the disagreement in sample classification or regression by
using various learning algorithms. In other words, the
different learning algorithms reveal the diversity of base
models [18]. This approach is being adopted in this study
to embrace the strengths of multiple algorithms.
Stacking [19] is an example of multiple learning algo-
rithms. It aggregates the results from the base models,
which are generated by different learning algorithms.
Using a meta-learner, it tries to combine the results from
these base learners in an optimal way to maximise the
generalisation capability [20]. Breiman [21] proposed an
approach called stacked regression. This approach was a
linear combination of predictions from Subset Regression
(SR) and Ridge Regression (RR). The researcher showed
that the prediction performance of a stacked model was
better than using SR or RR alone. Later on, Kedarisetti et
al. [22] applied an improved stacking method, stacking
C, to combine outputs from 5 classifiers, namely Logistic
Regression (LR), Support Vector Machine (SVM), Near-
est-neighbor algorithm and decision trees. They found
that the classification performance using stacking C
method outperformed those approaches using voting and
multi-scheme.
It can be concluded from the above studies that stacking
appears to be a good approach to combine predictions of
several learning algorithms. The combined classifiers or
regression models give better predictive accuracy than any
single base learner. However, there is no unique way to
combine the predictions of base learners using stacking.
Simple linear regression with non-negative constraints is a
simple way and it should usually work well [21].
Stacking multivariate linear regression (SMLR)
Based on the approach of ensemble learning of stacking,
in this study SMLR was proposed as the model for her-
bal medicines’ bioactivity prediction. Essentially, SMLR
combines the predictions from PCR [23], PLSR [24,25],
OPLS [26] and EN [27,28] with non-negative constraints
or coefficients. Then, the trained SMLR is used to pre-
dict the testing set of the chromatographic fingerprints.
The four underlying justifications for using PCR, PLSR,
OPLS, and EN to build base learners are: firstly, these
four methods can all work within the constraint of the
size of sample is much smaller than the number of pre-
dictors. Secondly, PLSR and OPLS are the most com-
monly used methods to model the correlation between
chromatographic fingerprints and the bioactivity of her-
bal medicines. Thirdly, PCR and EN are included to
increase the diversity of base learners, as it has been
reported that the biggest gains come when dissimilar sets
of base learners are stacked [21]. PCR is different from
PLSR and OPLS by extracting principal components that
retain as much variation as possible in original space.
The original data are projected to the new space (formed
by the principal components), called scores. Then, PCR
models the scores and the responses using Multivariate
Linear Regression (MLR). EN is a regularisation method
which adds two penalties to the least squares function
(cost function) to penalise the regression coefficients of
predictive models, this method is particularly useful
when the dataset is sparse. Fourthly, only linear regres-
sion learning algorithms are considered in this study due
to the fact that the linear models can be easily interpreted
which is useful for the identification of highly bioactive
regions or compounds in chromatographic fingerprints.
The outputs from the base learners are treated as
inputs to train the meta-model, called Meta-Learning
instances that are the predictions of base learners. The
number of predictor variables of a Meta-Learning
instance is the number of base learners. To train the
meta-model, Meta-Learning training samples need to be
formed. A 10-fold cross-validation is used for splitting an
original training set into ten folds. Each time, one fold is
held out to build the base learners using samples in the
remaining nine folds. The base learners are trained on
this dataset and to predict the responses in the holdout
set. These predicted responses are then used to form the
Meta-Learning training data. The rationale of these pro-
cedures is to ensure the Meta-Learning training data are
able to reflect the true prediction performance of the
base learners without bias and accurately [20].
The learning algorithm used for the development of
the meta-model is RR [29]. It is under the constraint
that the regression coefficients are non-negative, since
the responses of a sample predicted using PCR, PLSR,
OPLS, and EN models respectively are usually strongly
correlated. RR adds l2 penalty to the least squares
function (cost function) as a regularisation method.
Constraining regression coefficients to be non-negative
is to guarantee the response of a sample predicted by
the meta-model will be within the range (minimum
prediction of base learners, maximum prediction of
base learners) in case the prediction of the meta-model
is poor [21].
Chen et al. BMC Bioinformatics 2015, 16(Suppl 12):S4
http://www.biomedcentral.com/1471-2105/16/S12/S4
Page 3 of 8
After determining the coefficients of PCR, PLSR,
OPLS and EN models in the combination (meta-model),
PCR, PLSR, OPLS, and EN models will be built using
the original training set. When SMLR is used to predict
a new sample; the sample is firstly predicted by PCR,
PLSR, OPLS, and EN models that built on the original
training set: each base model gives a predicted response
of the sample. These predicted responses are then fed
into the meta-model which combines them into a final
predicted response.
The mathematical description of the strategy used for
combining PCR, PLSR, OPLS, and EN in SMLR is as
follows: suppose we have k base predictive models,
v1(x), v2(x), . . . , vk(x) , where x represents the predictor
variables, stacking combines the predictions of these
models rather than a single learner. The specific method
for combination in SMLR is defined as follows: given an
original training set T = {(yn, xn
)
,n = 1, 2, . . . ,N }, and a




, where xn is the predictor vari-
able and each x is p-dimensional, yn is the response.
Divide the data in T into 10 (almost) equal parts
T1,T2, . . . T10 using tenfold cross-validation, and define
Tj = T − Tj , where j = 1, 2, . . . , 10 . Using data in Tj
train the PCR, PLSR, OPLS and EN models respectively,
let vjk(x) , where k = 1, 2, 3, 4 denotes the predictive
model built using Tj. Specifically, vj1 (x) is the PCR
model trained using Tj, vj2 (x) is the PLSR model
trained using Tj, vj3 (x) is the OPLS model trained using
Tj, and vj4 (x) is the EN model trained using T
j. Take













which is used to penalise ak [21].
Then, develop vk (xn) using the training set T. The





Regression coefficients of original predictor variables
need to be further calculated by using the following
equation:
βSMLR = αPCR × βPCR + αPLSR × βPLSR + αOPLS × βOPLS + αEN × βEN (3)
where βSMLR , βPCR , βPLSR , βOPLS , and βEN represent
the regression coefficients of the original predictor vari-
ables in SMLR, PCR, PLSR, OPLS and EN models
respectively. The αPCR,αPLSR,αOPLS,αEN are the coeffi-
cients of PCR, PLSR, OPLS and EN models respectively.
Measures of predicting performance
In this study, mean-squared error (MSE) is used to mea-
sure the predictive performance of a predictive model.









where yˆi is the predicted response of the i
thsample, yi
is the observed response of the ith sample, and N is
number of samples.
The prediction error of a numeric prediction model









where yˆit is the predicted response of the i
th sample in
the test set, yit is the observed response of the i
th sam-
ple in the test set, and T is the number of samples in
the test set.
The prediction error of a numeric prediction model










where yˆip is the predicted response of the i
th sample in
the training set, yip is the observed response of the i
th
sample in the training set, and P is number of samples
in the training set.
Results and discussion
Experiments
The experiment was designed to evaluate the perfor-
mance of predictive models built by SMLR, and to com-
pare the prediction performance of SMLR with that of
PCR, PLSR, OPLS and EN respectively, using data of 72
chromatographic fingerprints of AR samples and their
corresponding bioactivity, CD80.
The 72 chromatographic fingerprints of AR extracts
were first pre-processed for baseline removal using
adaptive Iteratively Reweighted Penalised Least Squares
(airPLS) [30,31], alignment of chromatographic finger-
prints using Correlation Optimized Warping (COW)
[32-37], and standardisation. The chromatographic fin-
gerprints after pre-treatment were then split into a
training set and a test set using a bootstrap resampling
procedure [20], and this procedure was repeated ten
times, so there were ten training sets and ten test sets.
PCR, PLSR, OPLS, EN and SMLR were applied to each
training set to build prediction models, where they were
evaluated using the corresponding test set.
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Data description
Based on the Traditional Chinese Medicine concepts, AR
was chosen in this study because this herb has been
believed to enhance the important “qi” of humans that ele-
vates the general well-being and protection against dis-
eases and infections. However, up to now, there is no
quantifiable measurement of such “qi” in evidence-based
medicine. The hypothesis taken in this study is that herbs
that have been traditionally showing the desirable effect of
“qi” enhancement will also upregulate the body’s natural
immunity - therefore the expression level of the costimula-
tory molecules of CD80 on our body’s professional antigen
presenting cells of DCs was measured [38-40].
Three batches of raw AR (AR-A, AR-B, AR-C) were
used to prepare 72 extracts in total (24 extracts each)
according to a modified extraction method based on the
Chinese Pharmacopeia. These extracts were analysed by
high performance liquid chromatography with diode array
detector (HPLC-DAD) to obtain chromatographic finger-
prints. Briefly, 4 grams of raw herb were pre-immersing
with bi-distilled water (100, 150, 200 and 250 mL) for
12 hours and refluxed for 0, 1, 2, 3 and 4 hours. The mix-
tures were then filtered and concentrated under a rotary
evaporator (Brand, Germany). AR extracts were finally
obtained after lyophilisation. Each extract was stored
under low humidity condition and was kept for biological
assay within 3 months. All the extracts before chromato-
graphic analysis and biological assay were filtered under
0.2um filter. Bi-distilled water was produced in-house by
Milli-Q® Advantage A10 water purification systems (Milli-
pore; USA) and filtered with 0.22 μm Millipak®. All other
chemicals and reagents used were of analytical grade
unless indicated otherwise. The bioactivity CD80 was mea-
sured through a THP-1 DC flow cytometric platform.
Since a chromatographic run was 70 min long and the
sampling rate was 0.0067 min, the number of points
acquired per chromatographic fingerprint of AR was
10,501. In other words, each chromatographic finger-
print is a signal graph with 10,501 data points, with the
interval between two points being 0.0067 min.
Digitised chromatographic fingerprints of AR were gath-
ered in a 72 by 10,501 matrix X where each row represents
the fingerprint of one sample and the 10,501 variables
(measuring time points) are the columns. The correspond-
ing bioactivity capacities were represented as a 72-row
vector y. When building predictive models, all these
10,501 points of each digitised chromatogram were used
as predictor variables, and the CD80 capacity of each sam-
ple is the response.
Results
The MSEtest and MSEtraining of each model built by PCR,
PLSR, OPLS, EN and SMLR are listed in Table 1 and 2.
The numbers in the first column of Table 1 and 2
represent the predictive model built using the first train-
ing set, second training set, ... etc.
The difference of the predicted bioactivity capacity of
a test sample and its corresponding observed bioactivity
capacity is another measurement to study and to ana-
lyse. The criteria of how good the bioactivity capacity of
a new sample is predicted are listed in Table 3.
The difference between the predicted CD80 expression
and the observed response of a test sample can be
divided into different grades. In general, CD80 flow
cytometric expression for replicates of the same RA
extract have a standard deviation of about 2% of the
mean value. Thus a prediction of <10% difference can
be considered as excellent; and between 10-20% is good
and so on. The first column of Table 3 is the difference
of the predicted bioactivity capacity of a test sample and
its corresponding observed bioactivity capacity in per-
centage. The second column displays the four levels,
namely excellent, good, acceptable and poor of how
good the prediction is.
Table 1. the MSEtest of each predictive model build by
PCR, PLSR, OPLS, EN and SMLR
MSEtest
Test Set PCR PLSR OPLS EN SMLR
1 0.18545 0.17693 0.17693 0.14299 0.16524
2 0.26334 0.29223 0.29223 0.27688 0.27026
3 0.22515 0.21094 0.21094 0.18428 0.18602
4 0.27171 0.25480 0.25480 0.26347 0.25632
5 0.20965 0.19050 0.19050 0.22645 0.19704
6 0.33327 0.32225 0.32225 0.30530 0.30847
7 0.23789 0.22115 0.22115 0.24703 0.21343
8 0.25015 0.22506 0.23109 0.24708 0.22395
9 0.18473 0.17900 0.17900 0.20893 0.18507
10 0.27251 0.26961 0.26961 0.27560 0.26843
Mean 0.24339 0.23425 0.23485 0.23780 0.22742
Table 2. the MSEtraining of each predictive model build by
PCR, PLSR, OPLS, EN and SMLR
MSEtraining
Training Set PCR PLSR OPLS EN SMLR
1 0.05722 0.01562 0.01562 0.04591 0.02273
2 0.07726 0.02304 0.02304 0.0688 0.0339
3 0.05432 0.00992 0.00992 0.00278 0.01183
4 0.0372 0.02113 0.02113 0.17149 0.03334
5 0.02094 0.01609 0.01609 0.05693 0.0168
6 0.04337 0.02291 0.02291 0.20607 0.03839
7 0.03314 0.02129 0.02129 0.04031 0.01823
8 0.04345 0.01429 0.02959 0.04318 0.02377
9 0.0417 0.03122 0.03122 0.02044 0.02484
10 0.07736 0.01078 0.01078 0.07534 0.02725
Mean 0.0486 0.01863 0.02016 0.07313 0.02511
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The average difference (in percentage) of the predicted
bioactivity capacity of test samples and their corre-
sponding observed bioactivity capacity in each test set
(1,2, ..., 10) for PCR, PLSR, OPLS, EN and SMLR mod-
els can be found in Table 4. The numbers in the first
column of this table are the same as Table 1 and 2. In
order to analyse whether the mean MSEtest and the
mean differences of predicted responses and observed
responses of PCR, PLSR, OPLS, EN and SMLR are sig-
nificantly different, one-way ANOVA was applied. The
results are shown in Table 5 and 6.
Discussion
Comparing the MSEtest of predictive models built by
PCR, PLSR, OPLS, EN and SMLR, SMLR had the
smallest mean (0.22742), followed by PLSR (0.23425),
OPLS (0.23485), EN (0.23780) and PCR (0.24339),
though the differences of them were small, only at the
second, third, or even fourth decimal place. And these
differences were not statistically significant according
to the one-way ANOVA analysis results (F (4,45) =
0.15, p = 0.96).
In terms of the average difference of predicted
responses and observed responses in each test set for
models built by PCR, PLSR, OPLS, EN and SMLR,
SMLR had the smallest mean differences which is
13.40171%. PLS came second (13.44682%), OPLS came
third (13.47901%), followed by EN (13.54398%), and
PCR (13.93128%). Again, the differences among the
models were also small and not statistically significant;
the one-way ANOVA result is F (4,45) = 0.33, p = 0.86.
The mean differences between predicted CD80 capa-
city and observed CD80 capacity for SMLR, PCR, PLSR,
OPLS and EN are around 13% to 14%, which means
their predictions for CD80 capacity from chromato-
graphic fingerprints of AR samples are good, according
to the goodness criteria of predicting the bioactivity
capacity of a sample (Table 3).
The predicting performances of PCR, PLSR, OPLS, EN
and SMLR models, in terms of MSEtest and differences
between predicted responses and observed responses of
test samples, had the following ranking: SMLR, PLSR,
OPLS, EN and PCR. However, the improvement of pre-
dictive accuracy was not significant.
SMLR did not significantly improve the predictive
accuracy. This may be because the learning algorithm
applied in SMLR did not combine the predictions of
base learners in the optimal way. Another reason could
be that the size of samples is too small. There are not
enough samples to train the meta-model. In addition, if
more learning algorithms were used to create base mod-
els, the predictive accuracy might be improved to some
extent.
SMLR could also be applied in other domains, not just
for measuring the relationship between chromatographic
fingerprints and the bioactivity capacity of herbal medi-
cines. It is designed to solve the prediction problem
when the number of samples is far less than the number
of predictor variables, and when the predictor variables
are highly correlated.
Conclusions
In this article, SMLR was presented as an algorithm that
could develop predictive models for predicting bioactiv-
ity capacity of herbal medicines from their chromato-
graphic fingerprints. SMLR is a meta-learner that works
on the results the constituent base-learners. Its
Table 3. Criteria of goodness of prediction
Differences (%) How Good is the Prediction
≤ 10 Excellent
>10 & ≤20 Good
>20 & ≤30 Acceptable
> 30 Poor
Table 4. Average difference of predicted responses and
observed responses in each test set for each model
Difference (%)
Test Set PCR PLSR OPLS EN SMLR
1 12.72 12.089 12.089 10.9955 11.972
2 14.6231 14.972 14.972 13.635 14.2868
3 12.8561 12.6299 12.6299 11.5313 12.1758
4 15.1355 14.5171 14.5171 15.3884 14.8151
5 13.0635 12.3538 12.3538 13.8607 12.8326
6 14.6371 13.954 13.954 13.9972 13.9497
7 15.2913 14.5146 14.5146 14.8474 14.132
8 14.4245 14.0604 14.3823 13.9682 13.9149
9 12.1609 11.7033 11.7033 12.918 12.0041
10 14.4008 13.6742 13.6742 14.2981 13.9341
Mean 13.9313 13.4468 13.479 13.544 13.4017
Table 5. One-way ANOVA for the MSEtest of each model
of PCR, PLSR, OPLS, EN and SMLR
Source of Variation SS df MS F P-value F crit
Between Groups 0.00135 4 0.00034 0.14765 0.96311 2.57874
Within Groups 0.10264 45 0.00228
Total 0.10399 49
Table 6. One-way ANOVA for differences of predicted
and observed responses of PCR, PLSR, OPLS, EN, SMLR
Source of
Variation
SS df MS F P-value F crit
Between Groups 0.00018 4 4.56E-05 0.32640 0.85878 2.57874
Within Groups 0.00629 45 0.00014
Total 0.00647 49
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generalization capability becomes more obvious when its
constituent base-learners are more diversified in nature.
The prediction performances of models built by using
SMLR for predicting CD80 from the chromatographic
fingerprints of AR samples are superior to PCR, PLSR,
OPLS, and EN in terms of MSEtest and differences
between predicted responses and observed responses of
test samples. However, the differences among the mod-
els are small and not statistically significant.
Future work
Future studies should aim to further improve the pre-
dictive accuracy of the SMLR algorithm. For instance,
more learning algorithms can be attempted to generate
more training instances for the Meta-Learner. Another
possible investigation is the identification of base learners
that has maximum diversity, so that the Meta-Learner can
have optimal performance owing to the complementary
behavior of the constituent base learners. In addition,
other linear or non-linear learning algorithms could be
designed and applied for investigating how to combine the
output of the base learners in order to improve the predic-
tive accuracy. Furthermore, it is important to perform
CD80 bioactivity testing on those single chemical com-
pounds that has been predicted to be the highly bioactive
components. This may then demonstrate that this chemo-
metrics prediction platform has a strong potential to be an
effective drug discovery platform as well.
In this study, SMLR has been evaluated using only one
dataset, which does not appear to be that sufficient. In
the future, a few other datasets, with both quality che-
mical fingerprints and corresponding bioactivity results,
should be used for evaluation of the proposed approach
if possible. It is envisaged that this same platform may
be applicable for the analysis of other kinds of mixture
datasets not limited to the chromatographic fingerprints
and bioactivity capacity.
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Regression; PLSR: Partial Least Squares Regression; RF: Random Forests; RR:
Ridge Regression; SMLR: Staking Multivariate Linear Regression; SR: Subset
Regression; SVM: Support Vector Machine.
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